Partnering with Lundbeck

Lundbeck has always been a sales company. We have been active in the pharmaceutical industry since 1920 and in CNS research since 1950. Here are just some of the many other reasons why Lundbeck is an attractive partner:

• Long-term CNS heritage with proven track record
• Top management commitment to partnership
• Experienced worldwide marketing subsidiaries including Europe and US
• Strong opinion leader network
• Over 750 R&D staff
• World-class animal pharmacology
• Skilled in rapid clinical development

Our licensing review process

Here at Lundbeck, our in-licensing review process has five distinct phases:

• Phase A – Brief, non confidential, initial evaluation by Scientific Licensing Department
• Phase B – Fuller confidential evaluation by members of the R&D and marketing organisation.
• Phase C – Business case development and preliminary negotiation of principle agreement (term sheet)
• Phase D – Due diligence
• Phase E – Final negotiation and closing of contract

If you think there is basis for an on-going relationship with Lundbeck, please don’t hesitate to contact us. We look forward to hearing from you!